This webcast focuses on the role of wearable devices in the timely identification of atrial fibrillation (AF) and the evolving evidence around the rationale for and efficacy/safety of early rhythm control strategies, including guideline recommendations and expert insights on the use of antiarrhythmic drugs (AADs) and catheter ablation. It also incorporates an AI-powered patient simulator as a method by which participants can practice how they engage patients in shared decision-making discussions regarding rhythm control strategies.
Larry R. Jackson II, MD, MHSc, FACC, FAHA, FHRS
Cardiologist, Electrophysiologist
Associate Professor of Medicine
Department of Medicine, Division of Cardiovascular Medicine
Section, Adult Cardiac Electrophysiology
Duke Clinical Research Institute
Kristen Bova Campbell, PharmD, CPP, FACC, FHRS
Clinical Pharmacist Practitioner, Electrophysiology and Anticoagulation
Duke University Hospital